Botulinum Neurotoxin Type B Uses a Distinct Entry Pathway Mediated By Cdc42 Into Intestinal Cells Versus Neuronal Cells.

Abstract : Botulinum neurotoxins (BoNTs) are responsible for severe flaccid paralysis by inhibiting the release of acetylcholine at the neuromuscular junctions. BoNT/B most often induces mild forms of botulism with predominant dysautonomic symptoms. In food borne botulism and botulism by intestinal colonization such as infant botulism, which are the most frequent naturally acquired forms of botulism, the digestive tract is the main entry route of BoNTs into the organism. We previously showed that BoNT/B translocates through mouse intestinal barrier by an endocytosis-dependent mechanism and subsequently targets neuronal cells, mainly cholinergic neurons, in the intestinal mucosa and musculosa. Here we investigated the entry pathway of BoNT/B using fluorescent C-terminal domain of the heavy chain (HcB) which is involved in the binding to specific receptor(s) and entry process into target cells. While the combination of gangliosides GD1a /GD1b /GT1b and synaptotagmin I and to a greater extent synaptotagmin II constitutes the functional HcB receptor on NG108-15 neuronal cells, HcB only uses the gangliosides GD1a /GD1b /GT1b to efficiently bind to m-ICcl2 intestinal cells. HcB enters both cell types by a dynamin-dependent endocytosis which is efficiently prevented by Dynasore, a dynamin inhibitor, and reaches a common early endosomal compartment labeled by EEA1. In contrast to neuronal cells, HcB uses a Cdc42-dependent pathway to enter intestinal cells. Then, HcB is transported to late endosomes in neuronal cells, whereas it exploits a non-acidified pathway from apical to basal lateral side of m-ICcl2 cells supporting a transcytotic route in epithelial intestinal cells.
Type de document :
Article dans une revue
Cellular Microbiology, Wiley, 2017, 〈10.1111/cmi.12738〉
Liste complète des métadonnées

https://hal-pasteur.archives-ouvertes.fr/pasteur-01493360
Contributeur : Anne Lassailly-Bondaz <>
Soumis le : mardi 21 mars 2017 - 14:22:07
Dernière modification le : vendredi 16 mars 2018 - 09:36:01
Document(s) archivé(s) le : jeudi 22 juin 2017 - 13:00:14

Fichier

cmi12738.pdf
Fichiers produits par l'(les) auteur(s)

Licence


Distributed under a Creative Commons Paternité - Pas d'utilisation commerciale 4.0 International License

Identifiants

Collections

Citation

Chloé Connan, Marie Voillequin, Carolina Varela Chavez, Christelle Mazuet, Christian Leveque, et al.. Botulinum Neurotoxin Type B Uses a Distinct Entry Pathway Mediated By Cdc42 Into Intestinal Cells Versus Neuronal Cells.. Cellular Microbiology, Wiley, 2017, 〈10.1111/cmi.12738〉. 〈pasteur-01493360〉

Partager

Métriques

Consultations de la notice

141

Téléchargements de fichiers

26